NC
TMO icon

Northcape Capital’s Thermo Fisher Scientific TMO Stock Holding History

Northcape Capital’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-4,796
Closed -$2.76M – 31
2023
Q1 		$2.76M Buy
4,796
+1,746
+57% +$984K 0.34% 17
2022
Q4 		$1.68M Buy
+3,050
New +$1.62M 0.21% 18

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Northcape Capital's TMO Position: Q2 2023 in Review

Northcape Capital sold out of Thermo Fisher Scientific (TMO) in Q2 2023, closing a stake of 4,796 shares — an estimated $2.76M sold.

Northcape Capital first reported a position in TMO in Q4 2022 and held it in 2 quarters. The position peaked at $2.76M in Q1 2023. 2,389 funds tracked by Wall St. Rank hold TMO as of Q2 2023.

  • Northcape Capital reported no remaining Thermo Fisher Scientific position as of Q2 2023 after selling out during the quarter.
  • Northcape Capital sold 4,796 Thermo Fisher Scientific shares in Q2 2023, an estimated $2.76M.
  • Northcape Capital first reported a position in Thermo Fisher Scientific in Q4 2022 and held it in 2 quarters.
  • Northcape Capital's Thermo Fisher Scientific position peaked at $2.76M in Q1 2023.
  • 2,389 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2023.

Based on Northcape Capital's 13F filing for Q2 2023, filed 21 Jul 2023.